Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CLOV NYSE:CNC NYSE:HUM NYSE:MOH NASDAQ:TRUP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLOVClover Health Investments$3.11+1.8%$3.12$1.30▼$4.87$1.58B1.867.17 million shs3.81 million shsCNCCentene$32.02-1.8%$54.86$31.78▼$80.59$15.92B0.446.02 million shs7.76 million shsHUMHumana$234.73-1.2%$239.34$212.45▼$406.46$28.33B0.441.70 million shs169,237 shsMOHMolina Healthcare$230.33-0.3%$298.72$227.68▼$365.23$12.47B0.55738,516 shs161,781 shsTRUPTrupanion$52.01-0.8%$48.97$27.40▼$57.90$2.22B1.82614,909 shs65,246 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLOVClover Health Investments+5.54%+10.91%-0.33%-15.98%+129.32%CNCCentene-1.45%-42.52%-40.94%-48.00%-50.79%HUMHumana+0.22%-5.89%+3.10%-16.75%-35.88%MOHMolina Healthcare-0.98%-24.65%-22.05%-32.16%-21.15%TRUPTrupanion+1.10%-3.05%+6.05%+38.98%+80.86%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCLOVClover Health Investments2.3769 of 5 stars3.32.00.00.02.51.70.6CNCCentene4.9663 of 5 stars4.23.00.03.72.21.74.4HUMHumana4.6152 of 5 stars3.23.02.53.92.71.71.3MOHMolina Healthcare4.987 of 5 stars4.23.00.04.62.92.53.8TRUPTrupanion2.5234 of 5 stars1.41.00.03.01.90.81.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLOVClover Health Investments 2.67Moderate Buy$4.8355.66% UpsideCNCCentene 2.41Hold$68.87115.11% UpsideHUMHumana 2.30Hold$280.7619.61% UpsideMOHMolina Healthcare 2.44Hold$364.2158.13% UpsideTRUPTrupanion 2.86Moderate Buy$53.803.45% UpsideCurrent Analyst Ratings BreakdownLatest CNC, HUM, MOH, TRUP, and CLOV Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/3/2025TRUPTrupanionPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$52.00 ➝ $62.007/2/2025CNCCenteneBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$65.00 ➝ $52.007/2/2025CNCCenteneBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$65.00 ➝ $45.007/2/2025CNCCenteneCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$90.00 ➝ $65.007/2/2025CNCCenteneJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Neutral$75.00 ➝ $48.007/2/2025CNCCenteneUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Neutral$80.00 ➝ $45.006/17/2025HUMHumanaBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$320.00 ➝ $260.006/17/2025HUMHumanaTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetHold ➝ Hold$305.00 ➝ $280.006/12/2025HUMHumanaBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetEqual Weight ➝ Equal Weight$273.00 ➝ $268.006/9/2025CNCCenteneMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$70.006/9/2025MOHMolina HealthcareBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$351.00 ➝ $347.00(Data available from 7/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLOVClover Health Investments$1.37B1.15N/AN/A$0.68 per share4.57CNCCentene$163.07B0.10$9.59 per share3.34$52.49 per share0.61HUMHumana$117.76B0.24$23.61 per share9.94$136.57 per share1.72MOHMolina Healthcare$40.65B0.31$25.85 per share8.91$78.60 per share2.93TRUPTrupanion$1.29B1.73$0.29 per share181.07$7.63 per share6.82Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLOVClover Health Investments-$43.01M-$0.05N/AN/AN/A-1.69%-7.42%-4.00%8/4/2025 (Estimated)CNCCentene$3.31B$6.714.774.340.492.04%14.56%4.75%7/25/2025 (Estimated)HUMHumana$1.21B$14.1416.6017.881.791.42%14.47%5.03%7/30/2025 (Estimated)MOHMolina Healthcare$1.18B$20.7111.118.230.872.81%28.38%8.30%7/23/2025 (Estimated)TRUPTrupanion-$9.63M-$0.10N/A247.65N/A-0.32%-1.33%-0.52%8/14/2025 (Estimated)Latest CNC, HUM, MOH, TRUP, and CLOV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/4/2025Q2 2025CLOVClover Health Investments$0.03N/AN/AN/A$468.30 millionN/A7/30/2025Q2 2025HUMHumana$6.32N/AN/AN/A$31.85 billionN/A7/25/2025Q2 2025CNCCentene$2.07N/AN/AN/A$44.71 billionN/A7/23/2025Q2 2025MOHMolina Healthcare$6.12N/AN/AN/A$10.94 billionN/A5/6/2025Q1 2025CLOVClover Health Investments-$0.07$0.05+$0.12N/A$466.93 million$462.33 million5/1/2025Q1 2025TRUPTrupanion-$0.05-$0.03+$0.02-$0.03$337.81 million$341.98 million4/30/2025Q1 2025HUMHumana$10.07$11.58+$1.51$10.30$32.00 billion$32.11 billion4/25/2025Q1 2025CNCCentene$2.52$2.90+$0.38$2.63$43.16 billion$46.62 billion4/23/2025Q1 2025MOHMolina Healthcare$5.96$6.08+$0.12$5.45$10.86 billion$11.15 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCLOVClover Health InvestmentsN/AN/AN/AN/AN/ACNCCenteneN/AN/AN/AN/AN/AHUMHumana$3.541.51%N/A25.04%N/AMOHMolina HealthcareN/AN/AN/AN/AN/ATRUPTrupanionN/AN/AN/AN/AN/ALatest CNC, HUM, MOH, TRUP, and CLOV DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/17/2025HUMHumanaquarterly$0.88501.24%6/27/20256/27/20257/25/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLOVClover Health InvestmentsN/A1.541.54CNCCentene0.651.111.11HUMHumana0.711.911.91MOHMolina Healthcare0.871.631.63TRUPTrupanion0.381.701.70Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLOVClover Health Investments19.77%CNCCentene93.63%HUMHumana92.38%MOHMolina Healthcare98.50%TRUPTrupanionN/AInsider OwnershipCompanyInsider OwnershipCLOVClover Health Investments24.07%CNCCentene0.36%HUMHumana0.37%MOHMolina Healthcare1.26%TRUPTrupanion5.42%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLOVClover Health Investments680508.92 million386.42 millionOptionableCNCCentene60,500497.60 million495.81 millionOptionableHUMHumana65,680120.69 million120.25 millionOptionableMOHMolina Healthcare18,00054.20 million53.52 millionOptionableTRUPTrupanion1,13042.78 million40.47 millionOptionableCNC, HUM, MOH, TRUP, and CLOV HeadlinesRecent News About These CompaniesSpotting Winners: Trupanion (NASDAQ:TRUP) And Property & Casualty Insurance Stocks In Q1July 7 at 11:57 AM | msn.comTrupanion (TRUP) Gets a Buy from Piper SandlerJuly 5, 2025 | theglobeandmail.comPet injuries during the 4th of July and how to prevent themJuly 5, 2025 | msn.comBrokerages Set Trupanion, Inc. (NASDAQ:TRUP) Price Target at $51.80July 5, 2025 | americanbankingnews.comTrupanion (NASDAQ:TRUP) Price Target Raised to $62.00 at Piper SandlerJuly 4, 2025 | americanbankingnews.comTrupanion (NASDAQ:TRUP) Price Target Raised to $62.00July 3, 2025 | marketbeat.comTrupanion, Inc. (NASDAQ:TRUP) Shares Bought by Palisade Capital Management LPJuly 3, 2025 | marketbeat.comTrupanion, Inc. (NASDAQ:TRUP) Given Consensus Recommendation of "Moderate Buy" by AnalystsJuly 2, 2025 | marketbeat.comReport: Nevada sees rise in pet injuries from fireworks; 33 cases reported since 2020July 1, 2025 | msn.comTrupanion to Host 2025 Annual Investor Day on September 17June 26, 2025 | globenewswire.comSG Americas Securities LLC Buys New Position in Trupanion, Inc. (NASDAQ:TRUP)June 25, 2025 | marketbeat.comCat's meow: Vancouver Island tech named veterinary professional of the yearJune 23, 2025 | nanaimobulletin.comNCat's meow: Saanich vet tech named veterinary professional of the yearJune 21, 2025 | saanichnews.comSTrupanion Announces Winners of the Veterinary Appreciation Dayâ„¢ AwardsJune 18, 2025 | globenewswire.comZacks Industry Outlook Highlights Aflac, Unum, Trupanion, Globe Life and AMERISAFEJune 16, 2025 | finance.yahoo.comInvestors in Trupanion (NASDAQ:TRUP) have seen favorable returns of 92% over the past yearJune 14, 2025 | finance.yahoo.comTrupanion, Inc. (NASDAQ:TRUP) Shares Purchased by GAMMA Investing LLCJune 14, 2025 | marketbeat.com5 Accident & Health Insurance Stocks to Watch as Exposure IncreasesJune 13, 2025 | zacks.comTrupanion (TRUP) Upgraded to Buy: What Does It Mean for the Stock?June 9, 2025 | zacks.comFawwad Qureshi Sells 2,534 Shares of Trupanion, Inc. (NASDAQ:TRUP) StockJune 3, 2025 | insidertrades.comWhat dog owners need to know about foxtail this summerJune 2, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir Soon3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseWhy Centene Stock Dropped 40% — And Whether It's a Buy NowBy Leo Miller | July 8, 2025View Why Centene Stock Dropped 40% — And Whether It's a Buy NowCNC, HUM, MOH, TRUP, and CLOV Company DescriptionsClover Health Investments NASDAQ:CLOV$3.10 +0.06 (+1.80%) As of 11:34 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.Centene NYSE:CNC$32.02 -0.59 (-1.79%) As of 11:34 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.Humana NYSE:HUM$234.73 -2.76 (-1.16%) As of 11:34 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.Molina Healthcare NYSE:MOH$230.33 -0.69 (-0.30%) As of 11:34 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.Trupanion NASDAQ:TRUP$52.01 -0.44 (-0.85%) As of 11:33 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SoundHound Rises as Short Sellers Exit and AI Demand Grows Amazon's Prime Day Pullback Meets Bullish Golden Cross Signal Palantir’s Revenue Surge to $1B: Growth vs. Valuation Chime Financial: Analysts Ring In—And It’s a Buy Is Fortinet Ready to Break Out After Months of Consolidation? AST SpaceMobile: Is Market Noise Drowning Out a $100M Signal? CoreWeave's $9 Billion Power Play for Core Scientific Taiwan Semiconductor May Profit from Chinese Manufacturing Issues Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
